Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34 Filing Table of Contents
Document/ExhibitDescriptionPagesSize
1: 10-K Annual Report HTML 1.49M
2: EX-10.2 Material Contract HTML 35K
3: EX-10.3 Material Contract HTML 83K
4: EX-10.32 Material Contract HTML 57K
6: EX-21.1 Subsidiaries List HTML 128K
7: EX-23.1 Consent of Experts or Counsel HTML 34K
8: EX-24.1 Power of Attorney HTML 40K
5: EX-12.1 Statement re: Computation of Ratios HTML 45K
9: EX-31.1 Certification -- §302 - SOA'02 HTML 48K
10: EX-32.1 Certification -- §906 - SOA'02 HTML 36K
76: R1 Document and Entity Information Document HTML 63K
62: R2 Consolidated Balance Sheets HTML 152K
73: R3 Consolidated Balance Sheet (Parenthetical) HTML 68K
80: R4 Consolidated Statements of Operations HTML 123K
101: R5 Consolidated Statements of Comprehensive Income HTML 82K
64: R6 Consolidated Statements of Changes in HTML 113K
Shareholders' Equity
72: R7 Consolidated Statements of Cash Flows HTML 162K
55: R8 Description of Business (Notes) HTML 33K
45: R9 Basis of Presentation, Uses of Estimates and HTML 128K
Significant Accounting Policies (Notes)
103: R10 Investments (Notes) HTML 297K
82: R11 Fair Value (Notes) HTML 336K
81: R12 Property, Plant, and Capitalized Software (Notes) HTML 55K
88: R13 Goodwill and Intangible Assets (Notes) HTML 120K
89: R14 Medical Cost Reserve Development and Medical Costs HTML 61K
Payable (Notes)
86: R15 Commercial Paper and Long-Term Debt (Notes) HTML 222K
90: R16 Income Taxes (Notes) HTML 155K
74: R17 Shareholders' Equity (Notes) HTML 57K
77: R18 Share-Based Compensation (Notes) HTML 115K
84: R19 Commitments and Contingencies (Notes) HTML 58K
111: R20 Segment Financial Information (Notes) HTML 317K
97: R21 Quarterly Financial Data (Unaudited) (Notes) HTML 85K
68: R22 Schedule I (Notes) HTML 191K
83: R23 Basis of Presentation, Uses of Estimates and HTML 195K
Significant Accounting Policies (Policies)
70: R24 Fair Value Fair Value (Policies) HTML 48K
36: R25 Basis of Presentation, Uses of Estimates and HTML 88K
Significant Accounting Policies (Tables)
98: R26 Investments (Tables) HTML 300K
107: R27 Fair Value (Tables) HTML 329K
50: R28 Property, Plant, and Capitalized Software (Tables) HTML 53K
49: R29 Goodwill and Intangible Assets (Tables) HTML 123K
53: R30 Medical Cost Reserve Development and Medical Costs HTML 62K
Payable (Tables)
54: R31 Commercial Paper and Long-Term Debt (Tables) HTML 226K
57: R32 Income Taxes (Tables) HTML 177K
25: R33 Shareholders' Equity (Tables) HTML 41K
95: R34 Share-Based Compensation (Tables) HTML 115K
66: R35 Commitments and Contingencies Commitments and HTML 43K
Contingencies (Tables)
69: R36 Segment Financial Information (Tables) HTML 302K
40: R37 Quarterly Financial Data (Unaudited) (Tables) HTML 84K
110: R38 Schedule I (Tables) HTML 197K
17: R39 Basis of Presentation, Uses of Estimates and HTML 84K
Significant Accounting Policies (Details)
59: R40 Basis of Presentation, Uses of Estimates and HTML 46K
Significant Accounting Policies Medicare Part D
(Details)
100: R41 Basis of Presentation, Uses of Estimates and HTML 45K
Significant Accounting Policies Useful lives for
property, equipment and capitalized software
(Details)
38: R42 Basis of Presentation, Uses of Estimates and HTML 53K
Significant Accounting Policies Redeemable
Noncontrolling Interests (Details)
48: R43 Investments (Narrative) (Details) HTML 36K
52: R44 Investments (Short-Term and Long-Term Investments) HTML 137K
(Details)
63: R45 Investments (Fair Value of Mortgage-Backed HTML 114K
Securities by Credit Rating Origination) (Details)
24: R46 Investments (Amortized Cost and Fair Value of HTML 87K
Available-for-Sale Debt Securities by Contractual
Maturity) (Details)
44: R47 Investments (Amortized Cost and Fair Value of HTML 66K
Held-To-Maturity Debt Securities by Contractual
Maturity) (Details)
19: R48 Investments (Fair Value of Available-For-Sale HTML 117K
Investments with Gross Unrealized Losses by
Investment Type and Length of Time That Individual
Securities Have Been in a Continuous Unrealized
Loss Position) (Details)
99: R49 Investments (Net Realized Gains) (Details) HTML 72K
37: R50 Fair Value (Narrative) (Details) HTML 61K
96: R51 Fair Value (Financial Assets and Liabilities, HTML 145K
Excluding AARP, Measured at Fair Value on a
Recurring Basis) (Details)
41: R52 Fair Value (Financial Assets and Liabilities, HTML 127K
Excluding AARP, Not Measured at Fair Value on a
Recurring Basis) (Details)
60: R53 Fair Value (Reconciliation of Assets Measured at HTML 98K
Fair Value on a Recurring Basis Using Level 3
Inputs) (Details)
18: R54 Fair Value Fair Value Inputs Assets Quantitative HTML 52K
Information (Details)
22: R55 Fair Value (Assets and Liabilities measured at HTML 189K
fair value on a recurring basis) (Details)
51: R56 Property, Plant, and Capitalized Software HTML 38K
(Details)
29: R57 Property, Plant, and Capitalized Software Property HTML 62K
Plant and Equipment Table (Details)
104: R58 Goodwill and Intangible Assets (Details) HTML 36K
65: R59 Goodwill and Intangible Assets Changes in the HTML 64K
Carrying Amount of Goodwill by Reporting Segment
(Details)
87: R60 Goodwill and Intangible Assets Gross carrying HTML 63K
value, accumulated amortization and net carrying
value of intangible assets (Details)
43: R61 Goodwill and Intangible Assets Weighted-average HTML 48K
useful lives assigned to finite-lived intangible
assets acquired in business combinations (Details)
46: R62 Goodwill and Intangible Assets Amortization HTML 45K
Expense relating to Intangible Assets (Details)
94: R63 Medical Costs and Medical Costs Payable HTML 58K
Rollforward (Details)
91: R64 Commercial Paper and Long-Term Debt (Narrative) HTML 73K
(Details)
67: R65 Commercial Paper and Long-Term Debt (Details) HTML 271K
93: R66 Commercial Paper and Long-Term Debt Maturities of HTML 51K
commercial paper and long-term debt (Details)
42: R67 Commercial Paper and Long-Term Debt Fair Value HTML 46K
Hedges Statement of Financial Position Location
(Details)
71: R68 Commercial Paper and Long-Term Debt Fair Value HTML 48K
Hedges Effect of Changes in Fair Value Hedges on
Income (Details)
106: R69 Income Taxes (Details) HTML 64K
21: R70 Income Taxes Reconciliation of Provision for HTML 54K
Income Taxes (Details)
35: R71 Income Tax Reconciliation of the tax provision at HTML 84K
the U.S. Federal Statutory Rate (Details)
61: R72 Income Taxes Components of Deferred Tax Assets and HTML 102K
Liabilities (Details)
27: R73 Income Taxes Reconciliation of the beginning and HTML 53K
ending amount of unrecognized tax benefits
(Details)
109: R74 Shareholders' Equity (Details) HTML 70K
39: R75 Shareholders' Equity Dividends Paid (Details) HTML 38K
30: R76 Share-Based Compensation Narrative (Details) HTML 44K
34: R77 Share-Based Compensation (Stock Option and SAR HTML 86K
Activity) (Details)
23: R78 Share-Based Compensation (Restricted Share HTML 53K
Activity) (Details)
26: R79 Share-Based Compensation Other Share-Based HTML 75K
Compensation Data (Details)
78: R80 Share-Based Compensation (Share-Based Compensation HTML 64K
Principal Fair Value Assumptions) (Details)
32: R81 Commitments and Contingencies (Details) HTML 70K
105: R82 Commitments and Contingencies Future Lease HTML 50K
Payments (Details)
58: R83 Segment Financial Information (Narrative) HTML 49K
(Details)
85: R84 Segment Financial Information (Details) HTML 261K
92: R85 Quarterly Financial Data (Unaudited) (Details) HTML 87K
31: R86 Schedule I (Details) HTML 65K
33: R87 Schedule I Condensed Balance Sheets (Details) HTML 132K
102: R88 Schedule I Balance Sheet Document (Details) HTML 64K
28: R89 Schedule I Condensed Statement of Comprehensive HTML 88K
Income (Details)
79: R90 Schedule I Statement of Cash Flows (Details) HTML 127K
75: R91 Schedule I Maturities of Commercial Paper and HTML 56K
Long-Term Debt (Details)
108: XML IDEA XML File -- Filing Summary XML 169K
20: EXCEL IDEA Workbook of Financial Reports XLSX 447K
47: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 4.36M
11: EX-101.INS XBRL Instance -- unh-20141231 XML 6.68M
13: EX-101.CAL XBRL Calculations -- unh-20141231_cal XML 313K
14: EX-101.DEF XBRL Definitions -- unh-20141231_def XML 1.53M
15: EX-101.LAB XBRL Labels -- unh-20141231_lab XML 2.64M
16: EX-101.PRE XBRL Presentations -- unh-20141231_pre XML 1.75M
12: EX-101.SCH XBRL Schema -- unh-20141231 XSD 252K
56: ZIP XBRL Zipped Folder -- 0000731766-15-000007-xbrl Zip 458K
THIS CERTIFIES THAT UnitedHealth Group Incorporated (the “Company”) has on the award date specified above (the “Award Date”) granted to
[Participant
Name]
(the “Optionee”) the option (the “Option”) to purchase that number of shares of UnitedHealth Group Incorporated Common Stock, $.01 par value per share (the “Common Stock”), indicated above (the “Option Shares”). The Option that this Award represents will expire on the expiration date indicated above (the “Expiration Date”), unless it is terminated prior to that time in accordance with this Award.
The Option Shares represented by this Award shall become exercisable as follows: __% on each of the _________ anniversaries, unless this Option shall have terminated or the vesting shall have accelerated as provided in this Award. Once this Option has become exercisable for all or a portion of the Option Shares, it will remain exercisable for all or such portion of the Option Shares, as the case may
be, until the Option expires or is terminated as provided in this Award.
By accepting this Award, the Optionee acknowledges that the Optionee will not have any of the rights of a shareholder with respect to the Option Shares until the Option has been duly exercised and the exercise price indicated above (the “Exercise Price”) and applicable withholding taxes paid in accordance with this Award. The Optionee further acknowledges and agrees that the Company may deliver, by electronic mail, the use of the Internet, including through the website of the agent appointed by the Committee to administer the UnitedHealth Group Incorporated 2011 Stock Incentive Plan (the “Plan”), the
Company intranet web pages or otherwise, any information concerning the Company, this Award, the Plan pursuant to which the Company granted this Award, and any information required by the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.
This Option is subject to the further terms and conditions set forth below and to the terms of the Plan. A copy of the Plan is available upon request. In the event of any conflict between the terms of the Plan and this Award, the terms of the Plan shall govern. Any terms not defined herein shall have the meaning set forth in the Plan.
*
* * * *
1. Nonqualified Option. The Company does not intend that the Option shall be an Incentive Stock Option governed by the provisions of Section 422 of the Internal Revenue Code of 1986, as amended.
2. Termination of Option. The Option shall terminate on the Expiration Date. The Option shall terminate prior to the Expiration Date if the Optionee ceases to be employed by the Company or any Affiliate, except that:
(a) General. Except as expressly provided in Section 10 or this Section 2, if prior to vesting of the Options as
set forth herein, the Optionee ceases to be an employee of the Company or any Affiliate for any reason (voluntary or involuntary), then the Optionee may, at any time within the Exercise Period (as defined below), exercise the Option to the extent of the full number of Option Shares which were exercisable and which the Optionee was entitled to purchase under the Option on the date of the termination of his or her employment.
(b) Death or Long-Term Disability. If the Optionee dies while employed by the Company or any Affiliate, or if the Optionee’s employment by the Company or any Affiliate is terminated due to the Optionee’s
failure to return to work as the result of a long-term disability which renders the Optionee incapable of performing his or her duties as determined under the provisions of the Company’s long-term disability insurance program (“Disability”), then: (i) all unvested Option Shares hereunder shall immediately vest and be exercisable, and (ii) the Optionee (or the Optionee’s personal representatives, administrators or guardians, as applicable, or any person or persons to whom the Option is transferred by will or the applicable laws of descent and distribution) may (subject to earlier expiration on the Expiration Date) at any time within a period of five years after the Optionee’s death or Disability, or for such other longer period established at the discretion of the Committee, exercise the Option to the extent of the full number of Option Shares which are exercisable following such
vesting.
(c) Severance. Subject to Section 10, if Optionee’s employment with the Company or any Affiliate terminates at a time when Optionee is not eligible for Retirement (as defined below) and, in the circumstances, Optionee is entitled to severance or separation pay, the following provisions will apply. If the Optionee is entitled to severance under the Company’s severance pay plan as in effect on the date hereof and the Optionee is not eligible for Retirement (as defined below) at the time of termination of employment, then the Option shall continue to vest and become exercisable for the period of such severance. If Optionee is entitled to severance under an employment agreement entered into with the
Company, then the Option shall continue to vest and become exercisable for the period of such severance that Optionee is entitled to receive as of the date hereof. If the Optionee is entitled to separation pay other than under the Company’s severance pay plan or an employment agreement, then vesting of the Option shall continue for the lesser of the period (i) the Optionee would have received payments under the severance pay plan as in effect on the date hereof, had the Optionee been eligible for such payments; or (ii) of separation pay. In either case, should the Optionee be paid in a lump sum versus bi-weekly payments, the Option shall continue to vest for the time in which severance or separation pay would have been paid had it been
2
paid
bi-weekly. Any portion of the Option that vests after the Optionee’s termination of employment pursuant to this Section 2(c) may be exercised during the Exercise Period (as defined below). For avoidance of doubt, any Options that are unvested on the date of termination of Optionee’s employment and do not vest under the schedule set forth herein during the applicable severance or separation pay period identified above in this Section 2(c) shall be forfeited.
(d) Retirement. If the Optionee’s employment by the Company or any Affiliate is terminated and at the time of termination the Optionee is eligible for Retirement, then (i) the Option shall continue to vest and become exercisable as if such termination of employment had not occurred and (ii) the Optionee may, at any time within the shorter
of (1) the Expiration Date of the Option, or (2) a period of five years after such termination of employment or for such other longer period established at the discretion of the Committee, exercise the Option to the extent of the full number of Option Shares which are then exercisable.
(e) For the purposes of this Award, “Exercise Period” shall mean the greater of: (i) a period of three months after the date of termination of the Optionee’s employment; (ii) a period of three months after vesting ceases as provided in Section 2(c) if Optionee receives severance or separation pay; or (iii) such other longer period established at the discretion of the Committee. This Option shall in no event be exercisable after the Expiration Date.
(f) For purposes of this Award, “Retirement” means the termination of employment of an Optionee who is age 55 or older with at least ten
years of Recognized Employment with the Company or any Affiliate other than by reason of (i) death or Disability or (ii) Cause.
(g) For purposes of this Award, “Recognized Employment” shall include only employment since the Optionee’s most recent date of hire by the Company or any Affiliate, and shall not include employment with a company acquired by UnitedHealth Group or any Affiliate before the date of such acquisition.
3. Forfeiture of Option and Shares. This section sets forth circumstances under which the Optionee shall forfeit all or a portion of the Options, or be required to repay the
Company for the value realized in respect of all or a portion of the Options.
(a) Violation of Restrictive Covenants. If the Optionee violates any provision of the Restrictive Covenants in Section 4 of this Award, then any (i) unvested Options and (ii) Options that vested within one year prior to the Optionee’s termination of employment with the Company or any Affiliate or at any time after such termination of employment and that have not been exercised shall be immediately cancelled and rendered null and void without any payment therefor (the “Forfeited Options”). If any such Forfeited Options have been exercised prior to the Optionee’s violation of the Restrictive Covenants, the Optionee shall be required to repay or otherwise reimburse the
Company, upon demand, an amount in cash or Common Stock having a value equal to the amount described in this Section 3(a) below.
To the extent that such Option Shares have been sold, the amount shall be the aggregate proceeds received from such sale of the net Option Shares acquired after
3
payment of the Exercise Price and any applicable taxes (“Net Option Shares”). To the extent that the Net Option Shares have not been sold at the time Company demand is made, the amount shall be the aggregate Fair Market Value of the Net Option Shares on the date the Forfeited Options were exercised.
(b) Fraud. If the Board determines that the
Optionee has engaged in fraud that, in whole or in part, caused the need for a material restatement of the Company’s consolidated financial statements, then any vested and unvested Options then held by the Optionee shall be immediately cancelled and rendered null and void without any payment therefor. In addition, for any Options that were exercised during the 12-month period following the first public issuance or filing with the Securities Exchange Commission (whichever occurs first) of the incorrect financial statements (the “Covered Options”), the Optionee shall be required to repay or otherwise reimburse the Company, upon demand, an amount in cash or Common Stock having a value equal to the amount described in this Section 3(b) below, depending on whether the Optionee still holds the Option
Shares acquired upon exercise of the Covered Options.
To the extent that such Option Shares have been sold, the amount shall be the aggregate proceeds received from such sale of the Net Option Shares. To the extent that the Net Option Shares have not been sold at the time Company demand is made, the amount shall be the aggregate Fair Market Value of the Net Option Shares on the date the Covered Options were exercised.
(c) In General. This section does not constitute the Company’s exclusive remedy for the Optionee’s violation of the Restrictive Covenants or commission of fraudulent conduct. As the forfeiture and repayment provisions are not adequate remedies at law, the
Company may seek any additional legal or equitable remedy, including injunctive relief, for any such violations. The provisions in this section are essential economic conditions to the Company’s grant of Options to the Optionee. By receiving the grant of Options hereunder, the Optionee agrees that the Company may deduct from any amounts it owes the Optionee from time to time (such as wages or other compensation, deferred compensation credits, vacation pay, any severance or other payments owed following a termination of employment, as well as any other amounts owed to the Optionee by the Company) to the extent of any amounts the Optionee owes the
Company under this section. The provisions of this section and any amounts repayable by the Optionee hereunder are intended to be in addition to any rights to repayment the Company may have under Section 304 of the Sarbanes-Oxley Act of 2002 and other applicable law.
4. Restrictive Covenants. In consideration of the terms of this Award and the Company’s sharing of Confidential Information with the Optionee, the Optionee agrees to the Restrictive Covenants set forth below. For purposes of these Restrictive Covenants, the “Company” means UnitedHealth Group Incorporated and all of any Affiliate and other affiliates.
(a) Confidential
Information. The Optionee will be given access to and provided with sensitive, confidential, proprietary and trade secret information (“Confidential Information”) in the course of the Optionee’s employment. Examples of Confidential Information include: inventions; new product or
4
marketing plans; business strategies and plans; merger and acquisition targets; financial and pricing information; computer programs, source codes, models and databases; analytical models; customer lists and information; and supplier and vendor lists and other information which is not generally available to the public. The Optionee agrees not to disclose or use Confidential Information, either during or after the Optionee’s employment with the
Company, except as necessary to perform the Optionee’s duties or as the Company may consent in writing.
(b) Non-Solicitation. During the Optionee’s employment and for the greater of two years after the termination of the Optionee’s employment for any reason whatsoever, or the period of time for which the Option remains exercisable, the Optionee may not, without the Company’s prior written consent, directly or indirectly, for the Optionee or for any other person or entity, as agent, employee, officer, director, consultant, owner, principal, partner or shareholder, or in any other individual or representative capacity:
(i)
Solicit
or conduct business with any business competitive with the Company from any person or entity: (A) who was a Company provider or customer within the 12 months before Optionee’s employment termination and with whom Optionee had contact regarding the Company’s activity, products or services, or for whom Optionee provided services or supervised employees who provided those services, or about whom the Optionee learned Confidential Information during employment related to the Company’s provision of products or services to such Company provider or customer, or (B) was a prospective provider or customer the Company solicited within the 12 months
before Optionee’s employment termination and with whom Optionee had contact for the purposes of soliciting the person or entity to become a provider or customer of the Company, or supervised employees who had those contacts, or about whom the Optionee learned Confidential Information during employment related to the Company’s provision of products or services to such prospective Company provider or customer;
(ii)
Raid, hire, employ, recruit or solicit any Company employee or consultant who possesses Confidential Information of the
Company to leave the Company;
(iii)
Induce or influence any Company employee, consultant, or provider who possesses Confidential Information of the Company to terminate his, her or its employment or other relationship with the Company; or
(i)
Assist
anyone in any of the activities listed above.
(c) Non-Competition. During the Optionee’s employment and for the greater of one year after the termination of the Optionee’s employment for any reason whatsoever or the period of time for which the Option remains exercisable, the Optionee may not, without the Company’s prior written consent, directly or
5
indirectly, for the Optionee or for any other person or entity, as agent, employee, officer, director, consultant, owner, principal, partner or shareholder, or in any other individual or representative
capacity:
(i)
Engage in or participate in any activity that competes, directly or indirectly, with any Company activity, product or service that Optionee engaged in, participated in, or had Confidential Information about during Optionee’s last 36 months of employment with the Company; or
(ii)
Assist anyone in any of the activities listed above.
Notwithstanding the foregoing, this Section 4(c)
will apply to the extent permissible under the ABA Model Rules of Professional Conduct’s provisions regarding restrictions on the right to practice law or any applicable state counterpart.
(d) Because the Company’s business competes on a nationwide basis, the Optionee’s obligations under this “Restrictive Covenants” section shall apply on a nationwide basis anywhere in the United States.
(e) To the extent Optionee and the Company agree at any time to enter into separate agreements containing restrictive covenants with different or inconsistent terms than those contained herein, Optionee and the Company acknowledge and
agree that such different or inconsistent terms shall not in any way affect or have relevance to the Restrictive Covenants contained herein.
By accepting this Option, the Optionee agrees that the provisions of this Restrictive Covenants section are reasonable and necessary to protect the legitimate interests of the Company.
5. Manner of Exercise. On the terms set forth herein, the Option may be exercised by the Optionee in whole or in part from time to time by delivering notice of exercise (in a form and manner acceptable to the Company) to the Company or the Committee’s designated agent,
accompanied by payment of the Exercise Price and any applicable withholding taxes (i) in cash, by wire transfer, certified check or bank cashier’s check payable to the Company, (ii) by delivery of shares of Common Stock already owned by the Optionee, (iii) by withholding shares of Common Stock from the total number of shares of Common Stock acquired upon exercise under this Award having a fair market value, on the exercise date, equal to the aggregate Exercise Price and any applicable withholding taxes, or (iv) by delivery of a combination of cash, withholding of shares of Common Stock acquired upon exercise of this Award, and/or delivery of shares of Common Stock already owned by the Optionee; provided, that the Optionee shall not be entitled to tender shares of Common Stock pursuant to successive, substantially simultaneous exercises of options to purchase Common Stock. Any shares
already owned by the Optionee referred to in the preceding sentence must have been owned by the Optionee for no less than six months prior to the date of exercise of the Option if such shares were acquired upon the exercise of another option or upon the vesting of restricted stock or restricted stock units. To the extent the vested and
6
exercisable portion of the Option remains unexercised as of the close of business on the date the Option expires (the Expiration Date or such earlier date that is the last date on which the Option may be exercised pursuant to the terms of this Award), that portion of the Option will be exercised without any action by the Optionee in accordance with the terms of this Certificate if the Fair Market Value of a Share on that date is at least $0.01
greater than the Exercise Price and the exercise will result in Optionee receiving at least one Share. Notwithstanding anything to the contrary in this Award, the Company shall not be required to issue or deliver any shares of Common Stock upon exercise of any Option until the requirements of any federal or state securities laws, rules or regulations or other laws or rules (including the rules of any securities exchange) as may be determined by the Company to be applicable have been and continue to be satisfied (including an effective registration of the shares under federal and state securities laws).
6. No Guarantee of Employment. This Award does not confer on the Optionee any right to continued employment or
any other relationship with the Company or any Affiliate, nor will it interfere in any way with the right of the Company to terminate Optionee at any time. Optionee’s employment with the Company is at will.
7. No Transfer. During the Optionee’s lifetime, only the Optionee can exercise the Option. The Optionee may not transfer the Option except by will or the laws of descent and distribution, or pursuant to a domestic relations order as described in the Code or Title I of the Employee Retirement Income Security Act (or the rules promulgated thereunder), to the extent provided in Section 2 (b) entitled “Termination of Option.”
Any attempt to otherwise transfer the Option shall be void.
8. Special Restriction on Transfer for Certain Optionees. If the Optionee is an officer of the Company within the meaning of Section 16 of the Securities Exchange Act of 1934 and Rule 16a-1 issued thereunder, as such status is reasonably determined from time to time by the Board of Directors of the Company (a “Section 16 Officer”), at any time that the Option is exercised in whole or in part and the Company has theretofore communicated the Optionee’s status as a Section 16 Officer to the Optionee, the following special transfer restrictions apply to any shares
of Common Stock acquired upon the exercise of the Option. One-third (1/3) of the net number of any shares of Common Stock acquired upon the exercise of the Option at a time when the Optionee is a Section 16 Officer (including any shares of Common Stock or other securities subject to the Option following any adjustment made pursuant to this Option or Section 7 of the Plan) must be retained, and may not be sold or otherwise transferred, for a period of at least one year following the date the Option is exercised. For purposes of this Option, the “net number of any shares of Common Stock acquired” shall mean the number of shares of Common Stock received with respect to the particular exercise after reduction for any shares of Common Stock withheld by or tendered to the Company, or sold on the market, to cover the Exercise Price of the Option and/or to cover any federal, state,
local or other payroll, withholding, income or other applicable tax withholding required in connection with the exercise of the Option. The restrictions of this Section 8 are in addition to, and not in lieu of, the restrictions imposed under other Company policies and applicable laws.
9. Adjustments to Option Shares. In the event that any dividend or other distribution (whether in the form of cash, shares of Common Stock, other securities or
7
other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase or exchange of Shares or other securities of the
Company or other similar corporate transaction or event affecting the Shares would be reasonably likely to result in the diminution or enlargement of any of the benefits or potential benefits intended to be made available under the Option (including, without limitation, the benefits or potential benefits of provisions relating to the term, vesting or exercisability of the Option), the Committee shall, in such manner as it shall deem equitable or appropriate in order to prevent such diminution or enlargement of any such benefits or potential benefits, adjust any or all of (a) the number and type of shares (or other securities or other property) subject to the Option and (b) the exercise price with respect to the Option; provided, however, that the number of shares covered by the Option shall always be a whole number. Without limiting the foregoing, if any capital reorganization or reclassification of the capital stock of the
Company, or consolidation or merger of the Company with another entity, or the sale of all or substantially all of the Company’s assets to another entity, shall be effected in such a way that holders of the Company’s Common Stock shall be entitled to receive stock, securities, cash or other assets with respect to or in exchange for such shares, the Optionee shall have the right to purchase and receive upon the basis and upon the terms and conditions specified in this Award and in lieu of the shares of Common Stock of the Company immediately theretofore purchasable and receivable upon the exercise of the Option, with appropriate adjustments
to prevent diminution or enlargement of benefits or potential benefits intended to be made available under the Option, such shares of stock, other securities, cash or other assets as would have been issued or delivered to the Optionee if the Optionee had exercised the Option and had received such shares of Common Stock prior to such reorganization, reclassification, consolidation, merger or sale. The Company shall not effect any such reorganization, consolidation, merger or sale unless prior to the consummation thereof the successor entity (if other than the Company) resulting from such reorganization, consolidation or merger or the entity purchasing such assets shall assume by written instrument the obligation to deliver to the Optionee such shares of stock, securities, cash or other assets as, in accordance
with the foregoing provisions, the Optionee may be entitled to purchase or receive.
10. Certain Terminations on or After Change in Control. Notwithstanding the other vesting provisions set forth herein, but subject to the other terms and conditions set forth herein, the Option shall become fully vested and exercisable if, on or within two years after the effective date of a Change in Control, the Optionee ceases to be an employee of the Company or any Affiliate as a result of a termination of employment (i) by the Optionee for Good Reason, (ii) by the Company or any Affiliate without Cause, (iii) at a time when Optionee is eligible for Retirement, (iv) due to Optionee’s Disability, or (v) in the circumstances
described in Section 2(c). For purposes of this Award:
(a)
“Change in Control” shall mean the sale of all or substantially all of the Company’s assets or any merger, reorganization, or exchange or tender offer which, in each case, will result in a change in the power to elect 50% or more of the members of the Board of Directors of the Company; provided, however, that such a sale, merger or other event must also constitute either (i) a “change in the ownership” of the
Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(v), (ii) a “change in the effective control” of the Company
8
within the meaning of Treasury Regulation 1.409A-3(i)(5)(vi)(A)(1) (replacing “30 percent” with “50 percent” as used in such regulation), or (iii) a change “in the ownership of a substantial portion of the assets” of the Company within the meaning of Treasury Regulation 1.409A-3(i)(5)(vii).
(b)
“Cause”
shall mean Optionee’s (a) material failure to follow the Company’s reasonable direction or to perform any duties reasonably required on material matters, (b) material violation of, or failure to act upon or report known or suspected violations of, the Company’s Code of Conduct, as may be amended from time to time, (c) conviction of any felony, (d) commission of any criminal, fraudulent, or dishonest act in connection with Optionee’s employment, or (e) material breach of any employment agreement between the Optionee and the Company or any Affiliate, if any. The Company will, within 90 days of discovery of the conduct, give Optionee written
notice specifying the conduct constituting Cause in reasonable detail and Optionee will have 60 days to remedy such conduct, if such conduct is reasonably capable of being remedied. In any instance where the Company may have grounds for Cause, failure by the Company to provide written notice of the grounds for Cause within 90 days of discovery shall be a waiver of its right to assert the subject conduct as a basis for termination for Cause.
(c)
“Good Reason” shall mean the occurrence of any of the following without Optionee’s
written consent, in each case, when compared to the arrangements in effect immediately prior to the Change in Control:
(i)
any reduction in Optionee’s base salary or a significant reduction in Optionee’s total compensation;
(ii)
a reduction in Optionee’s annual or long-term incentive opportunities;
(iii)
a
diminution in Optionee’s duties, responsibilities or authority;
(iv)
a significant diminution in the budget over which the Optionee retains authority;
(v)
a change in Optionee’s reporting relationship; or
(vi)
a relocation of more than 25 miles from Optionee’s primary office location.
Optionee
will, within 90 days of discovery of such circumstances, give the Company written notice specifying the circumstances constituting Good Reason in reasonable detail; provided however that this notice period shall be shortened or waived to the extent necessary if compliance with the notice period would cause the termination for Good Reason to occur following the second anniversary of the effective date of the Change in Control. Except as contemplated by the preceding sentence, in any instance where Optionee may have grounds for Good Reason, failure by Optionee to provide written notice of the grounds for Good Reason within 90 days of discovery shall be a waiver of Optionee’s right to assert the subject circumstance as a basis for termination for Good Reason.
11. Narrowed Enforcement and Severability.
If a court or arbitrator decides that any provision of this Award is invalid or overbroad, the Optionee agrees that the
9
court or arbitrator should narrow such provision so that it is enforceable or, if narrowing is not possible or permissible, such provision should be considered severed and the other provisions of this Award should be unaffected.
12. Injunctive Relief. The Optionee agrees that (a) legal remedies (money damages) for any breach of the Restrictive Covenants in Section 4 of this Award will be inadequate, (b) the Company will suffer immediate
and irreparable harm from any such breach, and (c) the Company will be entitled to injunctive relief from a court in addition to any legal remedies the Company may seek in arbitration.
13. Survival. The Restrictive Covenants and provisions regarding the forfeiture of Options and shares in this Award shall survive the termination of the Option.
14. Other. An original record of this Award and all the terms thereof is held on file by the Company. To the extent there is any conflict between the terms contained in this Award and the terms
contained in the original held by the Company, the terms of the original held by the Company shall control. Neither the Plan nor the Option shall create or be construed to create a trust or separate fund of any kind or a fiduciary relationship between the Company or any Affiliate and Optionee or any other Person. To the extent that any Person acquires a right to receive payments from the Company or any Affiliate pursuant to an Option, such right shall be no greater than the right of any unsecured creditor of the Company or any Affiliate.
15. Governing
Law. The validity, construction and effect of this Award and any rules and regulations relating to this Award shall be determined in accordance with the laws of the State of Minnesota (without regard to its conflict of laws principles).
16. Code Section 409A. It is intended that this Award and any amounts payable under this Award shall either be exempt from or comply with Code Section 409A (including the Treasury regulations and other published guidance relating thereto) so as not to subject Optionee to payment of any additional tax, penalty or interest imposed under Code Section 409A. The provisions of this Award certificate shall be construed and interpreted to avoid the imputation of any such additional tax, penalty or interest under Code Section 409A yet preserve (to the nearest extent reasonably possible) the intended benefit payable to Optionee.
